Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
FFR-Guided Complete or Culprit-Only PCI in Patients with Myocardial Infarction.
Böhm F, Mogensen B, Engstrøm T, Stankovic G, Srdanovic I, Lønborg J, Zwackman S, Hamid M, Kellerth T, Lauermann J, Kajander OA, Andersson J, Linder R, Angerås O, Renlund H, Ērglis A, Menon M, Schultz C, Laine M, Held C, Rück A, Östlund O, James S; FULL REVASC Trial Investigators. Böhm F, et al. Among authors: ostlund o. N Engl J Med. 2024 Apr 25;390(16):1481-1492. doi: 10.1056/NEJMoa2314149. Epub 2024 Apr 8. N Engl J Med. 2024. PMID: 38587995 Clinical Trial.
Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction.
Yndigegn T, Lindahl B, Mars K, Alfredsson J, Benatar J, Brandin L, Erlinge D, Hallen O, Held C, Hjalmarsson P, Johansson P, Karlström P, Kellerth T, Marandi T, Ravn-Fischer A, Sundström J, Östlund O, Hofmann R, Jernberg T; REDUCE-AMI Investigators. Yndigegn T, et al. Among authors: ostlund o. N Engl J Med. 2024 Apr 18;390(15):1372-1381. doi: 10.1056/NEJMoa2401479. Epub 2024 Apr 7. N Engl J Med. 2024. PMID: 38587241 Clinical Trial.
Bivalirudin versus heparin in ST and non-ST-segment elevation myocardial infarction-Outcomes at two years.
Omerovic E, James S, Råmundal T, Fröbert O, Linder R, Danielewicz M, Hamid M, Pagonis C, Henareh L, Wagner H, Stewart J, Jensen J, Lindros P, Robertsson L, Wikström H, Ulvenstam A, Bhiladval P, Tödt T, Ioanes D, Kellerth T, Zagozdzon L, Götberg M, Andersson J, Angerås O, Östlund O, Held C, Koul S, Erlinge D. Omerovic E, et al. Among authors: ostlund o. Cardiovasc Revasc Med. 2024 Mar 26:S1553-8389(24)00113-1. doi: 10.1016/j.carrev.2024.03.025. Online ahead of print. Cardiovasc Revasc Med. 2024. PMID: 38575449
Design and rationale of the myocardial infarction and new treatment with metformin study (MIMET) - Study protocol for a registry-based randomised clinical trial.
Ritsinger V, Hagström E, Hambraeus K, James S, Jernberg T, Lagerqvist B, Leosdottir M, Lundman P, Pernow J, Östlund O, Norhammar A. Ritsinger V, et al. Among authors: ostlund o. J Diabetes Complications. 2023 Oct;37(10):108599. doi: 10.1016/j.jdiacomp.2023.108599. Epub 2023 Aug 30. J Diabetes Complications. 2023. PMID: 37683518 Free article.
Design and rationale of randomized evaluation of decreased usage of beta-blockers after acute myocardial infarction (REDUCE-AMI).
Yndigegn T, Lindahl B, Alfredsson J, Benatar J, Brandin L, Erlinge D, Haaga U, Held C, Johansson P, Karlström P, Kellerth T, Marandi T, Mars K, Ravn-Fischer A, Sundström J, Östlund O, Hofmann R, Jernberg T. Yndigegn T, et al. Among authors: ostlund o. Eur Heart J Cardiovasc Pharmacother. 2023 Feb 2;9(2):192-197. doi: 10.1093/ehjcvp/pvac070. Eur Heart J Cardiovasc Pharmacother. 2023. PMID: 36513329 Free PMC article. Clinical Trial.
Study protocol: The DAICY trial-dual versus single-antibiotic impregnated cement in primary hemiarthroplasty for femoral neck fracture-a register-based cluster-randomized crossover-controlled trial.
Mukka S, Hailer NP, Möller M, Gordon M, Lazarinis S, Rogmark C, Östlund O, Sköldenberg O, Wolf O; DAICY study group. Mukka S, et al. Among authors: ostlund o. Acta Orthop. 2022 Oct 5;93:794-800. doi: 10.2340/17453674.2022.4819. Acta Orthop. 2022. PMID: 36200646 Free PMC article.
Bivalirudin Versus Heparin Monotherapy in ST-Segment-Elevation Myocardial Infarction.
James S, Koul S, Andersson J, Angerås O, Bhiladvala P, Calais F, Danielewicz M, Fröbert O, Grimfjärd P, Götberg M, Henareh L, Ioanes D, Jensen J, Linder R, Lindroos P, Omerovic E, Panayi G, Råmunddal T, Sarno G, Ulvenstam A, Völtz S, Wagner H, Wikström H, Östlund O, Erlinge D. James S, et al. Among authors: ostlund o. Circ Cardiovasc Interv. 2021 Dec;14(12):e008969. doi: 10.1161/CIRCINTERVENTIONS.120.008969. Epub 2021 Dec 14. Circ Cardiovasc Interv. 2021. PMID: 34903034 Clinical Trial.
A registry-based randomised trial comparing an SGLT2 inhibitor and metformin as standard treatment of early stage type 2 diabetes (SMARTEST): Rationale, design and protocol.
Sundström J, Kristófi R, Östlund O, Bennet L, Eliasson B, Jansson S, Leksell J, Almby K, Lundqvist M, Eriksson JW; SMARTEST study group (see list in Appendix). Sundström J, et al. Among authors: ostlund o. J Diabetes Complications. 2021 Oct;35(10):107996. doi: 10.1016/j.jdiacomp.2021.107996. Epub 2021 Jul 21. J Diabetes Complications. 2021. PMID: 34389234 Free article.
47 results